Drug Shortage Report for TEVA-ZOPICLONE

Last updated on 2022-12-15 History
Report ID 124110
Drug Identification Number 02242481
Brand name TEVA-ZOPICLONE
Common or Proper name ZOPICLONE 7.5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ZOPICLONE
Strength(s) 7.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05CF
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-09-10
Estimated end date 2022-12-20
Actual end date 2022-12-14
Shortage status Resolved
Updated date 2022-12-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v52 2022-12-15 French Compare
v51 2022-12-15 English Compare
v50 2022-12-01 French Compare
v49 2022-12-01 English Compare
v48 2022-11-14 French Compare
v47 2022-11-14 English Compare
v46 2022-10-28 French Compare
v45 2022-10-28 English Compare
v44 2022-10-17 French Compare
v43 2022-10-17 English Compare
v42 2022-09-22 French Compare
v41 2022-09-22 English Compare
v40 2022-09-07 French Compare
v39 2022-09-07 English Compare
v38 2022-08-18 French Compare
v37 2022-08-18 English Compare
v36 2022-08-08 French Compare
v35 2022-08-08 English Compare
v34 2022-06-30 French Compare
v33 2022-06-30 English Compare

Showing 1 to 20 of 52